XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Financial Statement Details - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Accrued compensation $ 14,888 $ 9,582
Accrued clinical trial expenses 7,739 12,262
Liability to collaboration partners 3,495 3,808
Accrued contract termination costs 3,461 3,902
Other accrued expenses 7,827 7,003
Total accrued expenses $ 37,410 $ 36,557